JWJonathan D. Weiss

Jonathan D. Weiss

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jonathan D. Weiss has a total of 35 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A Low‐Cost, Open‐Source 3D Printer for Multimaterial and High‐Throughput Direct Ink Writing of Soft and Living Materials

    by Jonathan D. Weiss, Alana Mermin‐Bunnell, Fredrik S. Solberg, Tony Tam, Luca Rosalia, Amit Sharir, Dominic Rütsche, Soham Sinha, Perry S. Choi, Masafumi Shibata, et al.

    Direct ink writing is a 3D printing method that is compatible with a wide range of structural, elastomeric, electronic, and living materials, and it continues to expand its uses into physics, engineering, and biology laboratories. However, the large footprint, closed hardware and software ecosystems, and expense of commercial systems often hamper widespread adoption. This work introduces a compact, low‐cost, multimaterial, and high‐throughput direct ink writing 3D printer platform with detailed assembly files and instructions provided freely online. In contrast to existing low‐cost 3D printers and bioprinters, which typically modify off‐the‐shelf plastic 3D printers, this system is built from scratch, offering a lower cost and full customizability. Active mixing of cell‐laden bioinks, high‐throughput production of auxetic lattices using multimaterial multinozzle 3D (MM3D) printing methods, and a high‐toughness, photocurable hydrogel for fabrication of heart valves are introduced. Finally, hardware for embedded multinozzle and 3D gradient nozzle printing is developed for producing high‐throughput and graded 3D parts. This powerful, simple‐to‐build, and customizable printing platform can help stimulate a vibrant biomaker community of engineers, biologists, and educators.


  • Open Access

    A low-cost, open-source 3D printer for multimaterial and high-throughput direct ink writing of soft and living materials

    by Jonathan D. Weiss, Alana Mermin-Bunnell, Fredrik S. Solberg, Tony Tam, Luca Rosalia, Amit Sharir, Dominic Rütsche, Soham Sinha, Perry S. Choi, Masafumi Shibata, et al.

    Direct ink writing is a 3D printing method that is compatible with a wide range of structural, elastomeric, electronic, and living materials, and it continues to expand its uses into physics, engineering, and biology laboratories. However, the large footprint, closed hardware and software ecosystems, and expense of commercial systems often hamper widespread adoption. Here, we present a compact, simple-to-build, low-cost, multimaterial, and high-throughput direct ink writing 3D printer platform with detailed assembly files and instructions provided freely online. In contrast to existing low-cost 3D printers and bioprinters, which typically modify off-the-shelf plastic 3D printers, this system is built from scratch, offering a lower cost and full customizability. Despite its low cost, we demonstrate advanced active mixing and multimaterial multinozzle 3D (MM3D) printing methods, which previously have relied on expensive and custom motion control platforms. We finally introduce embedded multinozzle and 3D gradient nozzle designs that offer high throughput and graded 3D parts. This powerful, easy-to-build, and customizable printing platform can help stimulate a vibrant biomaker community of engineers, biologists, and educators.


  • Open Access

    Large‐Scale Production of Wholly Cellular Bioinks via the Optimization of Human Induced Pluripotent Stem Cell Aggregate Culture in Automated Bioreactors

    by Debbie L. L. Ho, Stacey Lee, Jianyi Du, Jonathan D. Weiss, Tony Tam, Soham Sinha, Danielle Klinger, Sean Devine, Art Hamfeldt, Hope T. Leng, et al.

    Combining the sustainable culture of billions of human cells and the bioprinting of wholly cellular bioinks offers a pathway toward organ‐scale tissue engineering. Traditional 2D culture methods are not inherently scalable due to cost, space, and handling constraints. Here, the suspension culture of human induced pluripotent stem cell‐derived aggregates (hAs) is optimized using an automated 250 mL stirred tank bioreactor system. Cell yield, aggregate morphology, and pluripotency marker expression are maintained over three serial passages in two distinct cell lines. Furthermore, it is demonstrated that the same optimized parameters can be scaled to an automated 1 L stirred tank bioreactor system. This 4‐day culture results in a 16.6‐ to 20.4‐fold expansion of cells, generating approximately 4 billion cells per vessel, while maintaining >94% expression of pluripotency markers. The pluripotent aggregates can be subsequently differentiated into derivatives of the three germ layers, including cardiac aggregates, and vascular, cortical and intestinal organoids. Finally, the aggregates are compacted into a wholly cellular bioink for rheological characterization and 3D bioprinting. The printed hAs are subsequently differentiated into neuronal and vascular tissue. This work demonstrates an optimized suspension culture‐to‐3D bioprinting pipeline that enables a sustainable approach to billion cell‐scale organ engineering.